Cushman & Wakefield [CWK] vs Colliers [CIGI] Detailed Stock Comparison
Cushman & Wakefield
NYSE
Loading...
Colliers
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Cushman & Wakefield wins in 8 metrics, Colliers wins in 11 metrics, with 0 ties. Colliers appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Cushman & Wakefield | Colliers | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.80 | 73.00 | Cushman & Wakefield |
| Price-to-Book Ratio | 1.80 | 5.97 | Cushman & Wakefield |
| Debt-to-Equity Ratio | 170.28 | 91.51 | Colliers |
| PEG Ratio | 0.05 | 16.82 | Cushman & Wakefield |
| EV/EBITDA | 10.75 | 18.60 | Cushman & Wakefield |
| Profit Margin (TTM) | 2.11% | 2.17% | Colliers |
| Operating Margin (TTM) | 4.94% | 8.55% | Colliers |
| EBITDA Margin (TTM) | 4.94% | 8.55% | Colliers |
| Return on Equity | 11.62% | 9.24% | Cushman & Wakefield |
| Return on Assets (TTM) | 3.78% | 3.84% | Colliers |
| Free Cash Flow (TTM) | $167.00M | $260.92M | Colliers |
| Dividend Yield | N/A | 0.23% | N/A |
| 1-Year Return | 10.76% | 11.94% | Colliers |
| Price-to-Sales Ratio (TTM) | 0.35 | 1.60 | Cushman & Wakefield |
| Enterprise Value | $6.05B | $11.52B | Colliers |
| EV/Revenue Ratio | 0.62 | 2.23 | Cushman & Wakefield |
| Gross Profit Margin (TTM) | 18.81% | 40.78% | Colliers |
| Revenue per Share (TTM) | $42 | $102 | Colliers |
| Earnings per Share (Diluted) | $0.88 | $2.23 | Colliers |
| Beta (Stock Volatility) | 1.51 | 1.60 | Cushman & Wakefield |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Cushman & Wakefield vs Colliers Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Cushman & Wakefield | 5.13% | -0.60% | 29.89% | 55.67% | 27.32% | 17.71% |
| Colliers | 2.93% | 0.39% | 16.55% | 36.41% | 29.69% | 21.13% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Cushman & Wakefield | 10.76% | -3.01% | 24.33% | -20.11% | -20.11% | -20.11% |
| Colliers | 11.94% | 34.38% | 151.87% | 277.72% | 1,231.91% | 1,107.42% |
Performance & Financial Health Analysis: Cushman & Wakefield vs Colliers
| Metric | CWK | CIGI |
|---|---|---|
| Market Information | ||
| Market Cap | $3.42B | $8.27B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 3,030,790 | 171,410 |
| 90 Day Avg. Volume | 2,429,037 | 156,430 |
| Last Close | $15.58 | $167.53 |
| 52 Week Range | $7.64 - $16.11 | $100.86 - $169.26 |
| % from 52W High | -3.29% | -1.02% |
| All-Time High | $23.54 (Feb 21, 2022) | $169.41 (Aug 22, 2025) |
| % from All-Time High | -33.81% | -1.11% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.18% |
| Quarterly Earnings Growth | 3.24% | -0.89% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.02% |
| Operating Margin (TTM) | 0.05% | 0.09% |
| Return on Equity (TTM) | 0.12% | 0.09% |
| Debt to Equity (MRQ) | 170.28 | 91.51 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.22 | $27.26 |
| Cash per Share (MRQ) | $2.67 | $4.79 |
| Operating Cash Flow (TTM) | $158.90M | $282.52M |
| Levered Free Cash Flow (TTM) | $537.49M | $284.33M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.23% |
| Last 12-Month Dividend | N/A | $0.30 |
Valuation & Enterprise Metrics Analysis: Cushman & Wakefield vs Colliers
| Metric | CWK | CIGI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.80 | 73.00 |
| Forward P/E | 12.53 | 16.82 |
| PEG Ratio | 0.05 | 16.82 |
| Price to Sales (TTM) | 0.35 | 1.60 |
| Price to Book (MRQ) | 1.80 | 5.97 |
| Market Capitalization | ||
| Market Capitalization | $3.42B | $8.27B |
| Enterprise Value | $6.05B | $11.52B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.62 | 2.23 |
| Enterprise to EBITDA | 10.75 | 18.60 |
| Risk & Other Metrics | ||
| Beta | 1.51 | 1.60 |
| Book Value per Share (MRQ) | $8.22 | $27.26 |
Financial Statements Comparison: Cushman & Wakefield vs Colliers
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CWK | CIGI |
|---|---|---|
| Revenue/Sales | $2.28B | $1.35B |
| Cost of Goods Sold | $1.90B | $798.06M |
| Gross Profit | $384.30M | $549.59M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $51.80M | $115.24M |
| EBITDA | $112.20M | $182.48M |
| Pre-Tax Income | $5.00M | $89.22M |
| Income Tax | $3.10M | $25.24M |
| Net Income (Profit) | $1.90M | $63.97M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CWK | CIGI |
|---|---|---|
| Cash & Equivalents | $623.20M | $186.32M |
| Total Current Assets | $2.60B | $1.59B |
| Total Current Liabilities | $2.20B | $1.35B |
| Long-Term Debt | $3.17B | $2.04B |
| Total Shareholders Equity | $1.78B | $2.50B |
| Retained Earnings | $-984.00M | N/A |
| Property, Plant & Equipment | $405.30M | $631.13M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CWK | CIGI |
|---|---|---|
| Operating Cash Flow | $35.30M | $-84.48M |
| Capital Expenditures | $-4.60M | $-14.65M |
| Free Cash Flow | $-166.60M | $-99.13M |
| Debt Repayment | $-31.40M | N/A |
| Common Stock Repurchase | $-10.20M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CWK | CIGI |
|---|---|---|
| Shares Short | 10.45M | 1.01M |
| Short Ratio | 4.97 | 7.15 |
| Short % of Float | 0.05% | N/A |
| Average Daily Volume (10 Day) | 3,030,790 | 171,410 |
| Average Daily Volume (90 Day) | 2,429,037 | 156,430 |
| Shares Outstanding | 229.70M | 50.61M |
| Float Shares | 228.62M | 40.04M |
| % Held by Insiders | 0.01% | 0.11% |
| % Held by Institutions | 0.95% | 0.80% |
Dividend Analysis & Yield Comparison: Cushman & Wakefield vs Colliers
| Metric | CWK | CIGI |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.30 |
| Last 12-Month Dividend Yield | N/A | 0.23% |
| 3-Year Avg Annual Dividend | N/A | $0.30 |
| 3-Year Avg Dividend Yield | N/A | 0.13% |
| 3-Year Total Dividends | N/A | $0.90 |
| Ex-Dividend Date | N/A | Jun 30, 2025 |